Literature DB >> 6788924

The effect of concurrent administration of valproate sodium on phenobarbital plasma concentration/dosage ratio in pediatric patients.

T Suganuma, T Ishizaki, K Chiba, M Hori.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6788924     DOI: 10.1016/s0022-3476(81)80488-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  8 in total

1.  In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).

Authors:  X Wen; J S Wang; K T Kivistö; P J Neuvonen; J T Backman
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

Review 2.  Pharmacokinetic variability of phenobarbital: a systematic review of population pharmacokinetic analysis.

Authors:  Janthima Methaneethorn; Nattawut Leelakanok
Journal:  Eur J Clin Pharmacol       Date:  2020-10-19       Impact factor: 2.953

Review 3.  Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations.

Authors:  R Riva; F Albani; M Contin; A Baruzzi
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

4.  Determination of phenobarbitone population clearance values for South African children.

Authors:  J H Botha; A L Gray; R Miller
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

5.  Inhibition of phenobarbitone N-glucosidation by valproate.

Authors:  I Bernus; R G Dickinson; W D Hooper; M J Eadie
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

Review 6.  Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide.

Authors:  D Battino; M Estienne; G Avanzini
Journal:  Clin Pharmacokinet       Date:  1995-10       Impact factor: 6.447

Review 7.  Drug interactions with valproic acid.

Authors:  R H Levy; K M Koch
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

8.  Inhibition of epoxidation of carbamazepine by valproic acid in the isolated perfused rat liver.

Authors:  S L Chang; R H Levy
Journal:  J Pharmacokinet Biopharm       Date:  1985-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.